DE69835601D1 - Zusammensetzungen und verfahren zur erhöhung des parazellulären transportes durch zellschichten - Google Patents

Zusammensetzungen und verfahren zur erhöhung des parazellulären transportes durch zellschichten

Info

Publication number
DE69835601D1
DE69835601D1 DE69835601T DE69835601T DE69835601D1 DE 69835601 D1 DE69835601 D1 DE 69835601D1 DE 69835601 T DE69835601 T DE 69835601T DE 69835601 T DE69835601 T DE 69835601T DE 69835601 D1 DE69835601 D1 DE 69835601D1
Authority
DE
Germany
Prior art keywords
transport
parazellular
compositions
increasing
cell layers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69835601T
Other languages
English (en)
Inventor
Daniel Joseph O'mahony
Gerard Cagney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merrion Research I Ltd
Original Assignee
Merrion Research I Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE19970794A external-priority patent/IE970794A1/en
Application filed by Merrion Research I Ltd filed Critical Merrion Research I Ltd
Application granted granted Critical
Publication of DE69835601D1 publication Critical patent/DE69835601D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Secondary Cells (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Fuel Cell (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69835601T 1997-09-24 1998-09-23 Zusammensetzungen und verfahren zur erhöhung des parazellulären transportes durch zellschichten Expired - Lifetime DE69835601D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5964497P 1997-09-24 1997-09-24
IE19970794A IE970794A1 (en) 1997-09-24 1997-11-10 Composition and method for enhancing paracellular transport across cell layers
PCT/IE1998/000080 WO1999015649A2 (en) 1997-09-24 1998-09-23 Composition and method for enhancing paracellular transport across cell layers

Publications (1)

Publication Number Publication Date
DE69835601D1 true DE69835601D1 (de) 2006-09-28

Family

ID=26320119

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835601T Expired - Lifetime DE69835601D1 (de) 1997-09-24 1998-09-23 Zusammensetzungen und verfahren zur erhöhung des parazellulären transportes durch zellschichten

Country Status (7)

Country Link
EP (1) EP1017801B1 (de)
JP (1) JP4330269B2 (de)
AT (1) ATE336574T1 (de)
AU (1) AU9182398A (de)
CA (1) CA2304313C (de)
DE (1) DE69835601D1 (de)
WO (1) WO1999015649A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4417000A (en) * 1999-04-15 2000-11-02 Glaxo Group Limited Novel pharmaceutical composition suitable for gene therapy
EP1768687A2 (de) * 2004-06-29 2007-04-04 Massachusetts Institute Of Technology Verfahren und zusammensetzungen in zusammenhang mit der modulation intrazellulärer verbindungen
JP2011501662A (ja) * 2007-10-12 2011-01-13 ザ・プロウボウスト・フェロウズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン・エリザベス・ニア・ダブリン タイト結合を開放するための方法
WO2011074578A1 (ja) 2009-12-14 2011-06-23 国立大学法人北海道大学 脂質膜構造体に細胞透過能を付与および/または脂質膜構造体の細胞透過能を増強するペプチド、ならびにそれらペプチドと結合した脂質を構成脂質として含む、細胞透過能を有するまたは細胞透過能が増強された脂質膜構造体
WO2012164546A2 (en) 2011-06-03 2012-12-06 Ecole Polytechnique Federale De Lausanne (Epfl) Microheater-based in situ self-cleaning dynamic stencil lithography

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1464704B1 (de) * 1996-03-07 2006-10-11 Eisai Co., Ltd. Mäuse Adhesions Molekül Occludin

Also Published As

Publication number Publication date
CA2304313A1 (en) 1999-04-01
WO1999015649A2 (en) 1999-04-01
AU9182398A (en) 1999-04-12
JP2001517436A (ja) 2001-10-09
CA2304313C (en) 2011-12-06
EP1017801B1 (de) 2006-08-16
WO1999015649A3 (en) 1999-05-20
EP1017801A2 (de) 2000-07-12
JP4330269B2 (ja) 2009-09-16
ATE336574T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
Burkert et al. Members of a readily enriched β-proteobacterial clade are common in surface waters of a humic lake
WO2006119266A3 (en) Human micrornas and methods for inhibiting same
ATE513910T1 (de) Methoden zur gensuppression mithilfe von rnai verstärkenden faktoren
WO2002059300A3 (en) Double-stranded rna-mediated gene suppression
ATE534732T1 (de) Molekulare targets und zusammensetzungen sowie verfahren zu deren identifikation zur behandlung von degenerations- und entzündungserkankungen
DE60227069D1 (de) VERFAHREN UND ZUSAMMENSETZUNGEN ZUR MODIFIKATION DER BEARBEITUNG VON APOLIPOPROTEIN B-mRNA
DE60335543D1 (de) Zusammensetzung und verfahren zur herstellung von nukleinsäuren aus sputum
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
ATE334657T1 (de) Hemmung der bcl-2 protein expression durch liposomale antisense-oligodeoxynukleotide
Bonilla-Findji et al. Viral and flagellate control of prokaryotic production and community structure in offshore Mediterranean waters
HK1053145A1 (en) Cloning and expressing an acid-resistant extracel lular lipase of yarrowia lipolytica
ATE458497T1 (de) Antagonisten von 'hedgehog' und 'patched' zur inhibierung des wachstums und der differenzierung von zellen und geweben, als auch deren verwendungen
DE69835601D1 (de) Zusammensetzungen und verfahren zur erhöhung des parazellulären transportes durch zellschichten
WO2004087207A3 (en) Method for inducing apoptosis and aneuploidy regression in cancer cells
SG158921A1 (en) Compositions and methods for short interfering nucleic acid inhibition of nav1.8
UA94231C2 (ru) Олигонуклеотиды или их функциональные гомологи, композиция, которая содержит их, и способ лечения в-клеточной опухоли
WO2002064840A3 (en) Methods for identifying compounds that inhibit or reduce ptp1b expression
TW200512293A (en) Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics
WO2004022782A3 (en) Compositions and methods for tissue specific or inducible inhibition of gene expression
Brown et al. Conservation genetics of the black rhinoceros (Diceros bicornis)
DE69623328D1 (de) Verwendung von mannanases als schleimkontrollmittel
Vera et al. Seasonal acclimatization of the carp involves differential expression of 5.8 S ribosomal RNA in pituitary cells
ATE520784T1 (de) Den transmembrantransport von nukleinsäuren fördernde nukleotidsequenzen
ATE477324T1 (de) Dna-enzym zur hemmung von plasminogenaktivator- inhibitor-1
DE60129577D1 (de) Verfahren zur minderung des nox-gehalts im verbrennungsgas aus verbrennungsöfen

Legal Events

Date Code Title Description
8332 No legal effect for de